
CALIGAN PARTNERS LP
Latest 13F filing data - Q1 2026
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
![]() | LQDA | 8.12M | $306.41M |
![]() | SABS | 7.97M | $30.51M |
![]() | IVA | 4.97M | $27.61M |
![]() | ADMA | 4.76M | $42.86M |
![]() | MLYS | 2.77M | $75.11M |
![]() | TNGX | 2.41M | $50.39M |
![]() | PCVX | 2.06M | $119.75M |
![]() | VOR | 1.93M | $34.34M |
![]() | RVMD | 1.65M | $160.74M |
![]() | AVTX | 1.64M | $24.41M |
![]() | EXEL | 1.55M | $66.62M |
![]() | ABVX | 1.46M | $162.79M |
![]() | LBRX | 1.44M | $34.63M |
![]() | ANIK | 1.44M | $20.81M |
![]() | XENE | 1.39M | $81.00M |
![]() | TYRA | 1.28M | $48.91M |
![]() | VRCA | 924K | $4.89M |
![]() | SYRE | 878K | $44.29M |
![]() | MBX | 849K | $25.33M |
![]() | MAZE | 615K | $18.36M |

Liquidia Corporation
LQDA
Shares Held
8.12M
Value
$306.41M

SAB Biotherapeutics, Inc.
SABS
Shares Held
7.97M
Value
$30.51M

Inventiva S.A.
IVA
Shares Held
4.97M
Value
$27.61M

ADMA Biologics, Inc.
ADMA
Shares Held
4.76M
Value
$42.86M

Mineralys Therapeutics, Inc.
MLYS
Shares Held
2.77M
Value
$75.11M

Tango Therapeutics, Inc.
TNGX
Shares Held
2.41M
Value
$50.39M

Vaxcyte, Inc.
PCVX
Shares Held
2.06M
Value
$119.75M

Vor Biopharma Inc.
VOR
Shares Held
1.93M
Value
$34.34M

Revolution Medicines, Inc.
RVMD
Shares Held
1.65M
Value
$160.74M

Avalo Therapeutics, Inc.
AVTX
Shares Held
1.64M
Value
$24.41M

Exelixis, Inc.
EXEL
Shares Held
1.55M
Value
$66.62M

Abivax S.A.
ABVX
Shares Held
1.46M
Value
$162.79M

LB Pharmaceuticals Inc Common Stock
LBRX
Shares Held
1.44M
Value
$34.63M

Anika Therapeutics, Inc.
ANIK
Shares Held
1.44M
Value
$20.81M

Xenon Pharmaceuticals Inc.
XENE
Shares Held
1.39M
Value
$81.00M

Tyra Biosciences, Inc.
TYRA
Shares Held
1.28M
Value
$48.91M

Verrica Pharmaceuticals Inc.
VRCA
Shares Held
924K
Value
$4.89M

Spyre Therapeutics, Inc.
SYRE
Shares Held
878K
Value
$44.29M

MBX Biosciences, Inc. Common Stock
MBX
Shares Held
849K
Value
$25.33M

Maze Therapeutics, Inc.
MAZE
Shares Held
615K
Value
$18.36M
